Organicell Regenerative Medicine, Inc. announced that it will receive $5,000,000 in funding on August 15, 2023. The company will issue common shares and convertible corporate debt in the transaction. The minimum investment accepted from any outside investor is $250,000.

The company will issue securities pursuant to exemption provided under Regulation D.